|
Market Closed -
OTC Markets
17:32:11 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.200 USD | +18.84% |
|
-.--% | +9.33% |
| 09-18 | Redcare extend gains, Deutsche Bank view and chart provide support | DP |
| 09-18 | Redcare Pharmacy NV : Deutsche Bank gives a Buy rating | ZD |
Company Valuation: Redcare Pharmacy NV
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,050 | 798.2 | 2,395 | 2,679 | 1,324 | 1,539 | - | - |
| Change | - | -61.07% | 200.06% | 11.86% | -50.57% | 16.23% | - | - |
| Enterprise Value (EV) 1 | 2,039 | 986.6 | 2,556 | 2,830 | 1,648 | 1,774 | 1,762 | 1,725 |
| Change | - | -51.62% | 159.04% | 10.72% | -41.74% | 7.6% | -0.66% | -2.12% |
| P/E | -27.3x | -10.2x | -180x | -58x | -34.8x | -142x | 65.7x | 27.3x |
| PBR | 4.94x | 2.26x | 5.09x | 5.54x | 2.85x | 3.23x | 3.03x | 2.7x |
| PEG | - | -2.49x | 2.2x | -0x | 2x | 2x | -0x | 0x |
| Capitalization / Revenue | 1.93x | 0.66x | 1.33x | 1.13x | 0.45x | 0.45x | 0.4x | 0.36x |
| EV / Revenue | 1.92x | 0.82x | 1.42x | 1.19x | 0.56x | 0.51x | 0.46x | 0.41x |
| EV / EBITDA | -408x | -123x | 47.8x | 85x | 28.7x | 18.5x | 13.3x | 10.1x |
| EV / EBIT | -63.1x | -20.7x | -674x | -81x | -135x | 70.1x | 28.9x | 17.7x |
| EV / FCF | -64.7x | -11.9x | 110x | -141x | -18.8x | -39.4x | 134x | 36.6x |
| FCF Yield | -1.55% | -8.38% | 0.91% | -0.71% | -5.31% | -2.54% | 0.75% | 2.73% |
| Dividend per Share 2 | - | - | - | - | - | 0.00667 | - | - |
| Rate of return | - | - | - | - | - | 0.01% | - | - |
| EPS 2 | -4.15 | -4.32 | -0.73 | -2.27 | -1.87 | -0.5267 | 1.138 | 2.736 |
| Distribution rate | - | - | - | - | - | -1.27% | - | - |
| Net sales 1 | 1,060 | 1,204 | 1,799 | 2,371 | 2,941 | 3,454 | 3,854 | 4,249 |
| EBITDA 1 | -5 | -8.044 | 53.5 | 33.3 | 57.4 | 96.06 | 132.5 | 170.1 |
| EBIT 1 | -32.3 | -47.55 | -3.793 | -34.91 | -12.2 | 25.29 | 60.87 | 97.34 |
| Net income 1 | -74.2 | -77.65 | -12.04 | -45.46 | -37.7 | -10.31 | 28.07 | 61.17 |
| Net Debt 1 | -10.98 | 188.4 | 160.7 | 150.5 | 324.2 | 234.5 | 222.7 | 185.4 |
| Reference price 2 | 113.30 | 44.11 | 131.60 | 131.70 | 65.10 | 74.80 | 74.80 | 74.80 |
| Nbr of stocks (in thousands) | 18,095 | 18,095 | 18,199 | 20,342 | 20,342 | 20,578 | - | - |
| Announcement Date | 02/03/22 | 07/03/23 | 05/03/24 | 11/03/25 | 03/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.52x | 0.73x | 10.88x | -.--% | 15.67B | |
| 23.98x | 0.97x | 10.48x | 1.86% | 7.07B | |
| 20.87x | 0.36x | 5.58x | 2.19% | 6.34B | |
| 16.56x | 0.73x | 7.65x | 2.26% | 6.34B | |
| 20.77x | 0.77x | 13.38x | 1.05% | 6.19B | |
| 16.13x | 1x | 7.04x | 2.62% | 4.54B | |
| 16.59x | 1.01x | 7.54x | 3.9% | 3.41B | |
| 15.93x | 0.46x | 7.71x | 1.32% | 3.24B | |
| 14.28x | 0.6x | 4.66x | 5.06% | 3.17B | |
| Average | 18.07x | 0.74x | 8.33x | 2.25% | 6.22B | |
| Weighted average by Cap. | 18.52x | 0.74x | 9.09x | 1.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RDC Stock
- SAEYY Stock
- Valuation Redcare Pharmacy NV
Select your edition
All financial news and data tailored to specific country editions
